Nurix: An Attractive Early-Stage Biotech Play
Nurix Therapeutics offers promising targeted protein degradation treatments for cancer and autoimmune diseases. Find out what ...
Armed robbery in Revesby1 天
Affordable Drugs Target Autoimmune, Cancer, Heart Ailments
Australians with types of vasculitis, leukaemia, heart disease, ulcerative colitis and arthritis now have access to new and ...
Pharmabiz4 天
US FDA accepts and grants priority review status to AstraZeneca’s sNDA for Calquence to ...
US FDA accepts and grants priority review status to AstraZeneca’s sNDA for Calquence to treat patients with untreated MCL: Cambridge, UK Friday, October 4, 2024, 09:00 Hrs [IST] ...
CALQUENCE® (acalabrutinib) granted Priority Review in the US for patients with untreated ...
AstraZeneca’s supplemental New Drug Application (sNDA) for CALQUENCE® (acalabrutinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with previously ...